You are viewing a preview of this job. Log in or register to view more details about this job.

Studies of Lung Cancer, Melanoma, and Kidney Cancer using Genomic Data - Postdoctoral Fellowship

Studies of Lung Cancer, Melanoma, and Kidney Cancer using Genomic Data - Postdoctoral Fellowship

We use genome-wide association studies (GWAS), next-generation sequencing analysis, and genome-wide methylation analysis to study risk and progression of lung cancer, melanoma, and kidney cancer. Specific goals of our research include:
  1. Identifying molecular signatures associated with environmental exposures and clinical outcomes;
  2. Identifying intra-tumor genetic and epigenetic heterogeneity and tumor evolution;
  3. Characterizing the molecular steps that lead from precursor to malignant disease;
  4. Identifying rare genetic variants associated with risk of familial melanoma.

All studies are large and population-based. We have strong collaborating biostatistics and laboratory teams, and have excellent computing resources for next-generation sequencing and genetic epidemiologic analyses.
DCEG fellows have access to data from state-of-the-art studies in cancer genomics and work with highly committed and talented researchers with expertise in epidemiology, biostatistics, and genomics. DCEG offers extensive career development training through its Office of Education.

Qualifications: Applicants with a doctoral degree or background in genetics/genomics, genetic epidemiology, or related field, are encouraged to apply. Experience in analyses of large complex genomic datasets, next-generation sequencing, GWAS, and/or bioinformatics methods is a plus. A successful candidate will have excellent communication skills, be highly motivated and able to work in a large multidisciplinary team. Salary and benefits are highly competitive and commensurate with experience.

For more information contact Maria Teresa Landi, M.D., Ph.D.

To Apply: See the Division Fellowship Information page for an overview, qualifications, and application details.